Back to index
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

alnylam.comBiopharmaceutical

What AI says about Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company that specializes in RNA interference (RNAi) therapeutics, aiming to silence genes that contribute to diseases. Their mission is to develop innovative medicines that can transform the lives of patients suffering from various conditions.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Not in this profile yet:

Company details

Products & Services

RNAi Therapeutics

An innovative class of medicines that treat diseases by silencing the genes responsible for them.

Common Questions

What is RNA interference (RNAi)?

RNA interference (RNAi) is a naturally occurring process that regulates gene expression by silencing specific genes to prevent the production of disease-causing proteins.

What types of diseases do Alnylam's therapeutics target?

Alnylam's RNAi therapeutics focus on both rare and prevalent diseases across several therapeutic areas.

How does Alnylam ensure patient-centered innovation?

Patients are at the center of Alnylam's mission, inspiring the company to innovate and develop treatments that improve their quality of life.

Company Information

Employees
201-1000
Industries
BiopharmaceuticalRNA TherapeuticsHealthcare